• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOK IRELAND LTD ZILVER VENA VENOUS SELF-EXPANDING STENT; Stent, iliac vein

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOK IRELAND LTD ZILVER VENA VENOUS SELF-EXPANDING STENT; Stent, iliac vein Back to Search Results
Model Number G57448
Device Problem Migration (4003)
Patient Problems Insufficient Information (4580); No Clinical Signs, Symptoms or Conditions (4582)
Event Type  Injury  
Manufacturer Narrative
Investigation is still pending, a follow up mdr will be submitted to include the investigation conclusions.510k: p200023.Product code: qan.
 
Event Description
Stent migration from right common fem to the atrium.Patient is stable and not symptomatic.Information from medwatch report received 01-oct-21: stent that was placed in right cfv (common femoral vein ) was found to have migrated to the patient ' s heart when he came into the hospital for another procedure.He underwent venogram for evaluation of the left iliac venous system when his right common iliac vein stent was observed within the right atrium.Cardiothoracic surgery and cardiology were consulted who recommended evaluation with echocardiography.This was obtained and the patient is now being admitted for observation overnight.
 
Manufacturer Narrative
Pma #: p200023.Product code: qan.Investigation is still pending, a follow up mdr will be submitted to include the investigation conclusions.
 
Event Description
Supplemental report due to updated description on event on 05-oct-21: stent migration from right common fem to the atrium.Patient is stable and not symptomatic.Information from medwatch report received 01-oct-21: stent that was placed in right cfv (common femoral vein ) was found to have migrated to the patient ' s heart when he came into the hospital for another procedure.He underwent venogram for evaluation of the left iliac venous system when his right common iliac vein stent was observed within the right atrium.Cardiothoracic surgery and cardiology were consulted who recommended evaluation with echocardiography.This was obtained and the patient is now being admitted for observation overnight.As per information recieved on 05-oct-21: 4.Are patient demographics available such as age, gender, weight or pre-existing conditions? yes.5.Where any type of interventional procedures performed due to the occurrence? ct removed the stent.
 
Event Description
Supplemental follow-up report is being submitted due to the completion of the investigation and an update to the investigation conclusions.
 
Manufacturer Narrative
Pma #: p200023.Product code: qan.The zvt7-35-80-16-100 device of lot number c1772420 involved in this complaint was implanted in the patient and was not available for evaluation.With the information provided, a document-based investigation was conducted.Prior to distribution zvt7-35-80-16-100 devices are subjected to a visual inspection and functional checks to ensure device integrity.These inspections and functional checks are outlined in internal procedures in place at cirl.A review of the manufacturing records for zvt7-35-80-16-100 of lot number c1772420 did not reveal any discrepancies that could have contributed to this complaint issue.The review of relevant manufacturing records confirms the failure mode has not previously occurred with the current lot number.Based on the information available to date, there is no evidence to suggest that there are any manufacturing issues associated with lot number c1772420.It should be noted that stent migration is listed as a known potential adverse event within the instructions for use.There is no evidence to suggest the user did not follow the ifu.A definitive root cause could not be determined from the available information.A possible root cause could be attributed to patients pre-existing condition, pts and scar tissue, which may have exerted high pressure on the stent.This could have contributed to the migration of the stent.The complaint is confirmed based on customer testimony.According to the initial reporter, the patient did experience adverse effects due to this occurrence.The patient required echocardiography and surgical intervention in order to remove the migrated device from the body.Complaints of this nature will continue to be monitored for potential emerging trends.
 
Manufacturer Narrative
Pma/510(k) # p200023.Common name- (b)(6).Device evaluation the zvt7-35-80-16-100 device of lot number c1772420 involved in this complaint was implanted in the patient and was not available for evaluation.With the information provided, a document-based investigation was conducted.Document review: prior to distribution zvt7-35-80-16-100 devices are subjected to a visual inspection and functional checks to ensure device integrity.These inspections and functional checks are outlined in internal procedures in place at cirl.A review of the manufacturing records for zvt7-35-80-16-100 of lot number c1772420 did not reveal any discrepancies that could have contributed to this complaint issue.The review of relevant manufacturing records confirms the failure mode has not previously occurred with the current lot number.Based on the information available to date, there is no evidence to suggest that there are any manufacturing issues associated with lot number c1772420.It should be noted that stent migration is listed as a known potential adverse event within the instructions for use, ifu0091-7.There is no evidence to suggest the user did not follow the ifu.Root cause review: a definitive root cause could not be determined from the available information.A possible root cause could be attributed to patients pre-existing condition, pts and scar tissue, which may have exerted high pressure on the stent.This could have contributed to the migration of the stent.As previously noted stent migration is listed as a known potential adverse event within the instructions for use.Summary: the complaint is confirmed based on customer testimony.According to the initial reporter, the patient did experience adverse effects due to this occurrence.The patient was stable and not symptomatic.The migration was noted when the patient came to the hospital for another procedure.The patient required echocardiography and surgical intervention in order to remove the migrated device from the body.Complaints of this nature will continue to be monitored for potential emerging trends.
 
Event Description
Supplemental correction report is being submitted following a review of this complaint file.Updates were made to annex e and f codes and investigation evaluation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ZILVER VENA VENOUS SELF-EXPANDING STENT
Type of Device
Stent, iliac vein
Manufacturer (Section D)
COOK IRELAND LTD
o halloran road
limerick
Manufacturer (Section G)
COOK IRELAND LTD
o halloran road
national technology park
limerick
Manufacturer Contact
sinead o'leary
o halloran road
national technology park
limerick 
061334440
MDR Report Key12596645
MDR Text Key277487321
Report Number3001845648-2021-00718
Device Sequence Number1
Product Code QAN
UDI-Device Identifier10827002574486
UDI-Public(01)10827002574486(17)231030(10)C1772420
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup,Followup
Report Date 09/10/2021,03/22/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/30/2023
Device Model NumberG57448
Device Catalogue NumberZVT7-35-80-16-100
Device Lot NumberC1772420
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Report Sent to FDA09/10/2021
Distributor Facility Aware Date09/10/2021
Event Location Hospital
Initial Date Manufacturer Received 09/16/2021
Initial Date FDA Received10/08/2021
Supplement Dates Manufacturer Received09/16/2021
09/16/2021
Not provided
Supplement Dates FDA Received11/03/2021
02/08/2022
04/19/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/30/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Required Intervention;
-
-